PRIM:NYSEPrimoris Services Corporation Analysis
Data as of 2026-05-19 - not real-time
$108.63
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Primoris Services (PRIM) is trading at $108.63, well above its DCF fair value of $20.23, indicating a substantial overvaluation despite a modest PE of 23.98 versus the industry average of 29.50. Technical indicators show a neutral trend with the 20‑day SMA ($146.53) and 50‑day SMA ($147.20) both far above the current price, a bearish MACD histogram (-5.24), and an RSI of 35.5 suggesting the stock is approaching oversold conditions. Recent news highlights a weak quarter, a 50% share price collapse, and revenue contraction of 5.4%, reinforcing the negative momentum. However, the company maintains a low payout ratio (7%), positive operating cash flow, and a dividend yield of 0.29%, which supports dividend sustainability. Analyst sentiment remains bullish with a consensus “buy” rating, a median target price of $149.5, and an upside potential of roughly 34% based on the upside/downside metric. The high beta (1.40) and extreme 30‑day volatility (213%) amplify price swings, while the debt‑to‑equity ratio of 55% and a max drawdown of 50% add financial stress. In summary, the stock is severely overvalued, faces short‑term downside pressure, but retains some medium‑term upside tied to improving earnings forecasts and dividend appeal, albeit with elevated risk.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Weak quarterly revenue and earnings
- Bearish MACD and oversold RSI
- Extreme short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward EPS guidance and lower forward PE (18.3)
- Analyst consensus buy with median target $149.5
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Current price far exceeds DCF fair value
- Persistent revenue decline and high debt load
- High beta and volatility indicating sustained risk
Key Metrics & Analysis
Financial Health
Revenue Growth-5.40%
Profit Margin3.31%
P/E Ratio24.0
ROE15.85%
ROA5.51%
Debt/Equity55.11
P/B Ratio3.5
Op. Cash Flow$281.6M
Free Cash Flow$128.2M
Industry P/E29.5
Technical Analysis
TrendNeutral
RSI35.5
Support$98.09
Resistance$205.50
MA 20$146.53
MA 50$147.20
MA 200$136.10
MACDBearish
VolumeIncreasing
Fear & Greed Index89.36
Valuation
Fair Value$20.23
Target Price$146.14
Upside/Downside34.53%
GradeOvervalued
TypeValue
Dividend Yield0.29%
Risk Assessment
Beta1.40
Volatility213.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.